STRS Ohio’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

STRS Ohio’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,000	Closed	-$1.59M	–	2323
2021 Q3	$1.59M	Sell	9,000 -6,000	-40%	-$965K	0.01%	821
2021 Q2	$2.42M	Sell	15,000 -11,200	-43%	-$1.8M	0.01%	675
2021 Q1	$4.49M	Buy	26,200 +15,100	+136%	+$2.99M	0.02%	511
2020 Q4	$2.44M	Buy	11,100 +4,800	+76%	+$1.04M	0.01%	638
2020 Q3	$1.05M	Buy	6,300 +800	+15%	+$109K	﹤0.01%	905
2020 Q2	$627K	Buy	5,500 +2,800	+104%	+$272K	﹤0.01%	1144
2020 Q1	$207K	Buy	2,700 +300	+13%	+$26.9K	﹤0.01%	1535
2019 Q4	$309K	Buy	2,400 +900	+60%	+$86.8K	﹤0.01%	1587
2019 Q3	$116K	Hold	1,500	–	–	﹤0.01%	1743
2019 Q2	$154K	Buy	+1,500	New	+$117K	﹤0.01%	1748
2014 Q4	–	Sell	-2,400	Closed	-$42K	–	1829
2014 Q3	$42K	Hold	2,400	–	–	﹤0.01%	1669
2014 Q2	$48K	Buy	+2,400	New	+$46.3K	﹤0.01%	1624

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

STRS Ohio's MRTX Position: Q4 2021 in Review

STRS Ohio sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2021, closing a stake of 9,000 shares — an estimated $1.59M sold.

STRS Ohio first reported a position in MRTX in Q2 2014 and held it in 12 quarters. The position peaked at $4.49M in Q1 2021. 260 funds tracked by Wall St. Rank hold MRTX as of Q4 2021.

STRS Ohio reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
STRS Ohio sold 9,000 Mirati Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $1.59M.
STRS Ohio first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2014 and held it in 12 quarters.
STRS Ohio's Mirati Therapeutics, Inc. Common Stock position peaked at $4.49M in Q1 2021.
260 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2021.

Based on STRS Ohio's 13F filing for Q4 2021, filed 24 Jan 2022.